上海凯宝：痰热清胶囊获药品注册证书 新增新冠病毒感染适应症

Core Viewpoint - Shanghai Kaibao has received a drug registration certificate from the National Medical Products Administration for its product, Phlegm Heat Clearing Capsules, which now includes a new indication for treating mild symptoms related to COVID-19 [1] Group 1: Product Information - Phlegm Heat Clearing Capsules are one of the main products of Shanghai Kaibao and are unique to the company [1] - The primary functions of the capsules include clearing heat, resolving phlegm, and detoxifying, specifically for conditions associated with wind-heat lung syndrome [1] Group 2: Market Impact - The approval of the new indication for COVID-19 will expand the product's applicability, enhancing market competitiveness and brand recognition for Shanghai Kaibao [1]